Literature DB >> 19944437

Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expression.

M Sarah Hill1, Autumn Ruiz, Kimberly Schmitt, Edward B Stephens.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) encodes for a Vpu protein, which interacts with CD4 resulting in its degradation. In this study, we examined the role of the 10 amino acids within the predicted second alpha-helical domain of the subtype B Vpu cytoplasmic tail in CD4 down-modulation using a VpuEGFP reporter system. Our findings indicate that the invariant leucine at position 63 and, to a lesser extent, the valine at position 68 were required for CD4 down-modulation. Mutation of analogous L63 in Vpu proteins subtypes A2, B(YU-2), C, D, and H also abolished CD4 down-modulation from the cell surface. Co-immunoprecipitation analysis revealed that L63A and V68A mutants were capable of binding CD4 and still retained the ability to interact with h-beta-TrCP1. Taken together, these results indicate that amino acid substitutions in the second alpha-helical domain that retain the predicted structure and binding to h-beta-TrCP1 can influence Vpu-mediated CD4 degradation. Copyright 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944437      PMCID: PMC4104991          DOI: 10.1016/j.virol.2009.10.048

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.

Authors:  T Klimkait; K Strebel; M D Hoggan; M A Martin; J M Orenstein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

2.  Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.

Authors:  Edward B Stephens; Coleen McCormick; Erik Pacyniak; Darcy Griffin; David M Pinson; Francis Sun; Warren Nothnick; Scott W Wong; Robert Gunderson; Nancy E J Berman; Dinesh K Singh
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

3.  A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.

Authors:  C McCormick-Davis; S B Dalton; D R Hout; D K Singh; N E Berman; C Yong; D M Pinson; L Foresman; E B Stephens
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

4.  A novel gene of HIV-1, vpu, and its 16-kilodalton product.

Authors:  K Strebel; T Klimkait; M A Martin
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

5.  Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.

Authors:  S Schwartz; B K Felber; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Identification of a protein encoded by the vpu gene of HIV-1.

Authors:  E A Cohen; E F Terwilliger; J G Sodroski; W A Haseltine
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 7.  Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1.

Authors:  David R Hout; Ellyn R Mulcahy; Erik Pacyniak; Lisa M Gomez; Melissa L Gomez; Edward B Stephens
Journal:  Curr HIV Res       Date:  2004-07       Impact factor: 1.581

8.  The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4(+) T cell loss caused by the simian-human immunodeficiency virus SHIV(KU-lbMC33) in pig-tailed macaques.

Authors:  Dinesh K Singh; Darcy M Griffin; Erik Pacyniak; Mollie Jackson; Michael J Werle; Bo Wisdom; Francis Sun; David R Hout; David M Pinson; Robert S Gunderson; Michael F Powers; Scott W Wong; Edward B Stephens
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

9.  CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.

Authors:  Yuzuru Imai; Mariko Soda; Shigetsugu Hatakeyama; Takumi Akagi; Tsutomu Hashikawa; Kei Ichi Nakayama; Ryosuke Takahashi
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

10.  HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Authors:  Bastien Mangeat; Gustavo Gers-Huber; Martin Lehmann; Madeleine Zufferey; Jeremy Luban; Vincent Piguet
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

View more
  11 in total

1.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

2.  Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.

Authors:  Cristian De Candia; Constanza Espada; Gabriel Duette; Yanina Ghiglione; Gabriela Turk; Horacio Salomón; Mauricio Carobene
Journal:  Virol J       Date:  2010-10-04       Impact factor: 4.099

3.  Structural determination of virus protein U from HIV-1 by NMR in membrane environments.

Authors:  Hua Zhang; Eugene C Lin; Bibhuti B Das; Ye Tian; Stanley J Opella
Journal:  Biochim Biophys Acta       Date:  2015-09-08

4.  Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.

Authors:  Takeshi Yoshida; Yoshio Koyanagi; Klaus Strebel
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

Review 5.  Modulation of HIV-1-host interaction: role of the Vpu accessory protein.

Authors:  Mathieu Dubé; Mariana G Bego; Catherine Paquay; Éric A Cohen
Journal:  Retrovirology       Date:  2010-12-22       Impact factor: 4.602

6.  Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.

Authors:  Susanna M Bächle; Daniel Sauter; Sabrina Sibitz; Johan K Sandberg; Frank Kirchhoff; Markus Moll
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

7.  The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4+ T cells.

Authors:  Emily N Pawlak; Brennan S Dirk; Rajesh Abraham Jacob; Aaron L Johnson; Jimmy D Dikeakos
Journal:  Retrovirology       Date:  2018-01-12       Impact factor: 4.602

8.  Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.

Authors:  Tiffany M Lucas; Sanath K Janaka; Edward B Stephens; Marc C Johnson
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

9.  Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.

Authors:  Suzanne Pickering; Stephane Hué; Eun-Young Kim; Susheel Reddy; Steven M Wolinsky; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2014-01-23       Impact factor: 6.823

Review 10.  Mechanisms underlying HIV-1 Vpu-mediated viral egress.

Authors:  Nicolas Roy; Grégory Pacini; Clarisse Berlioz-Torrent; Katy Janvier
Journal:  Front Microbiol       Date:  2014-05-01       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.